6/12+ Infection Control Tools

  • In mid-June 2019 a series of presentations on Infection Control, offering free CME/CE credits to physicians, nurses, and pharmacists, will expire.  CDC and Medscape produced them in 2017 with the intention that they’d be valid for two years.  The six presentations include Risk Recognition, Environmental Services, Medical Equipment, Nonsterile Gloves, Hierarchy of Controls, and Injection Safety.  Find them at https://www.cdc.gov/infectioncontrol/training/cme-info.html.

5/22 CMS/NKF Webinar on CKD Risk Reduction

CMS and NKF will present a May 22, 2019 webinar on on Population Health Strategies for Kidney Disease Risk Reduction, at noon PST.  Nephrologists, dialysis facility medical directors and renal care providers are invited and encouraged to attend. The NKF CKD Change Package will be introduced, systematic strategies for improving identification and management of CKD will be described, and a population health strategy for registry function, QI, and patient engagement for people living with CKD will be presented.  Register for the webinar at https://meetings-cms.webex.com/meetings-cms/onstage/g.php?MTID=e06e8b0a5642756b1b7a7e0998d0eeeb8.  Find the NKF CKD Change Package at https://www.kidney.org/sites/default/files/02-11-8036_JBI_CKD_ChangePackV17.pdf.

5/8-12 NKF Spring Clinical Meetings, Boston

The National Kidney Foundation 2019 Spring Clinical Meetings (SCM19) present a unique opportunity for renal health care providers to learn new developments related to all aspects of nephrology.  An important objective of SCM19 is to present the latest insights into CKD care through a combination of interesting courses, practical workshops, thought-provoking symposia and insightful debates.  SCM19 will be held May 8-12, 2019 in Boston MA.  In-person registration is allowed, but many registration fees are discounted if you register online before May 6.

Extra-cost pre-conference course topics on May 8 include dialysis success, vascular access, ultrasound, supportive care, and updates on new developments in transplant, critical care, and glomerular disease.  Topics for extra-cost lunch workshops during the conference will include vascular access, electrolytes, hyponatremia, glomerular disease, reproductive health, hypertension, communication, and board review.  For those unable to attend in person, live-streamed conference sessions will be available on burnout, obesity, safety, fluid management, opioids, social media, diabetes, community, lifestyle interventions, palliative care, and KDOQI update.

For more information and registration, see https://www.kidney.org/spring-clinical.

2/21+ UCLA/UKEEP Patient Education

The UCLA Health CORE Kidney program will present a February 21, 2019 webinar on Living Kidney Donation.  For details and pre-registration, see https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/UKEEP/ucla022119.pdf.

UKEEP will host a February 24, 2019 workshop on Kidney Disease: What You Should Know in Santa Monica CA.  See https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/UKEEP/UKEEP022419.pdf for details and RSVP information.

The CORE Kidney program will also present:

Find more information, and recordings of earlier CORE Kidney and UKEEP programs, at https://www.uclahealth.org/core-kidney/, along with information about the UCLA PKD program and other related educational outreach.

NW16 2/15+ NWRD Conference, Portland

Northwest Renal Dietitians will hold their 2019 Annual Conference March 7-8, 2019 in Portland OR.  Topics include cardiac dysfunction, change motivation, diabetes management, and an evening networking event.  For details see https://docs.wixstatic.com/ugd/412302_a994fa9b56104e058440b04e5eeab527.pdf.

Find Conference details at https://www.nwrdonline.org/conference-overview.  Volunteers are welcome and appreciated.  NWRD includes renal dietitians from British Columbia, as well as the five Network 16 states.  There is no NWRD membership fee.

NW16 10/4+ NWRD Conference, NWCRN News

NWRD Conference

Northwest Renal Dietitians have announced their 2019 Annual Conference, to be held March 7-8, 2019 in Portland OR.  Topics intended so far include cardiac dysfunction, change motivation, diabetes management, and an evening networking event.  For details see https://docs.wixstatic.com/ugd/412302_a994fa9b56104e058440b04e5eeab527.pdf.

To follow all Conference details as they develop, see https://www.nwrdonline.org/conference-overview.  Volunteers are welcome and appreciated.  NWRD includes renal dietitians from British Columbia, as well as the five Network 16 states.  There is no NWRD membership fee.

NKF Council on Renal Nutrition News

The Washington State Council on Renal Nutrition and the Oregon Council on Renal Nutrition, regional affiliates of the NKF Council on Renal Nutrition, are merging by January 1, 2019 to become the Northwest Council on Renal Nutrition, NWCRN.  NWCRN will be open to all renal dietitians in Network 16 – Washington, Oregon, Idaho, Montana, and Alaska.  The Oregon Council has closed, and until the new NWCRN website is available, any Network 16 dietitian may join the Washington State Council, at https://sites.google.com/site/washrenalnutrition/home/membership.

The Washington State Council holds bimonthly meetings, the last two of which in 2018 will be held in Seattle or by webinar on:

  • October 4, 2018 – Alkali Treatment in CKD
  • December 5, 2018 – Research for Dietitians

For more information see https://sites.google.com/site/washrenalnutrition/home, or email washcrn@gmail.comVolunteers are welcome and appreciated.  Handouts and minutes from past meetings are available at https://sites.google.com/site/washrenalnutrition/past-meetings.

FDA Warning re Cipro et al and Blood Sugar

The FDA has required new label warnings about blood sugar and mental health side effects of fluoroquinolone antibiotic drugs.  The most common fluoroquinolones are Cipro (ciprofloxacin), Avelox (moxifloxacin), and Levaquin (levofloxacin), but there are many others, most of which end in -floxacin.  The new label has many specific warnings and recommendations for diabetics.  For full details see https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm612979.htm.